These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 7294636)
1. Asymmetric anterior segment changes induced by chlorpromazine. Deluise VP; Flynn JT Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636 [TBL] [Abstract][Full Text] [Related]
2. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population. Alexander LJ; Bowerman L; Thompson LR J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212 [TBL] [Abstract][Full Text] [Related]
3. [Ocular involvement during prolonged treatment with neuroleptics]. Nouri A; Cuendet JF Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196 [No Abstract] [Full Text] [Related]
4. Deposits in the lens and cornea of the eye during long-term chlorpromazine medication. Rasmussen K; Kirk L; Faurbye A Acta Psychiatr Scand; 1976 Jan; 53(1):1-6. PubMed ID: 1251751 [TBL] [Abstract][Full Text] [Related]
5. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472 [No Abstract] [Full Text] [Related]
6. Ocular and cutaneous side effects after prolonged chlorpromazine treatment. Gombos GM; Yarden PE Am J Psychiatry; 1967 Jan; 123(7):872-4. PubMed ID: 6016858 [No Abstract] [Full Text] [Related]
7. Cutaneous and ocular changes associated with the use of chlorpromazine. Wolf ME; Richer S; Berk MA; Mosnaim AD Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679 [TBL] [Abstract][Full Text] [Related]
8. Total dosage of chlorpromazine and ocular opacities. Buffaloe WJ; Johnson AW; Sandifer MG Am J Psychiatry; 1967 Aug; 124(2):250-1. PubMed ID: 4951587 [No Abstract] [Full Text] [Related]
9. [Drug-induced eye lesions in the aged]. Slezak H Aktuelle Gerontol; 1983 Sep; 13(5):187-90. PubMed ID: 6139035 [TBL] [Abstract][Full Text] [Related]
11. [Ocular side effects of drugs]. Müller-Breitenkamp U; Hockwin O Laryngorhinootologie; 1992 Apr; 71(4):226-8. PubMed ID: 1575856 [TBL] [Abstract][Full Text] [Related]
12. Chlorpromazine-induced skin pigmentation with corneal and lens opacities. Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137 [TBL] [Abstract][Full Text] [Related]
13. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine. Gualtieri CT; Lefler WH; Guimond M; Staye JI Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312 [TBL] [Abstract][Full Text] [Related]
14. Incidence and significance of chlorpromazine-induced eye changes. De Long SL Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741 [No Abstract] [Full Text] [Related]
15. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs]. Francesconi G; Di Tizio A; Cameo D Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709 [No Abstract] [Full Text] [Related]
16. Toxic effects of phenothiazines on the eye. Boet DJ Doc Ophthalmol; 1970 Jul; 28(1):1-69. PubMed ID: 5312274 [No Abstract] [Full Text] [Related]